Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma
Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s9308
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
SAGE Publications